Figure 1
Pregabalin Capsule
Product Images NDC 80425-0152
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 10
Figure 11
Figure 12
Figure 2
Figure 3
Figure 4
This appears to be a chart displaying percentages of pain improvement for patients taking Pregabalin at varying dosages over a certain period, compared to a placebo group. However, the text is not clear enough to provide a fully accurate and useful description.*
Figure 5
Figure 6
Figure 7
Figure 9
The graph displays the percent improvement in pain from baseline for patients taking pregabalin at three different daily doses (300mg, 450mg, and 600mg) compared to a placebo group. The percent of patients improved is shown to be 100% for all three doses of pregabalin, whereas the placebo group had a lower percentage improvement. The values on the x-axis range from 210 to 290 and the y-axis measures percent improvement.*
Pregabalin 50 mg Cap Qty 30 80425 0152
Pregabalin 50 mg Cap Qty 60 80425 0152
Pregabalin 50 mg Cap Qty 90 80425 0152
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
